Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189 von Rodríguez-Abreu, D., Powell, S.F., Hochmair, M.J., Gadgeel, S., Esteban, E., Felip, E., Speranza, G., De Angelis, F., Dómine, M., Cheng, S.Y., Bischoff, H.G., Peled, N., Reck, M., Hui, R., Garon, E.B., Boyer, M., Kurata, T., Yang, J., Pietanza, M.C., Souza, F., Garassino, M.C.

Volltext

SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015 von García-Campelo, R., Bernabé, R., Cobo, M., Corral, J., Coves, J., Dómine, M., Nadal, E., Rodriguez-Abreu, D., Viñolas, N., Massuti, B.

Volltext

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer von Gandhi, Leena, Rodríguez-Abreu, Delvys, Gadgeel, Shirish, Esteban, Emilio, Felip, Enriqueta, De Angelis, Flávia, Domine, Manuel, Clingan, Philip, Hochmair, Maximilian J, Powell, Steven F, Cheng, Susanna Y.-S, Bischoff, Helge G, Peled, Nir, Grossi, Francesco, Jennens, Ross R, Reck, Martin, Hui, Rina, Garon, Edward B, Boyer, Michael, Rubio-Viqueira, Belén, Novello, Silvia, Kurata, Takayasu, Gray, Jhanelle E, Vida, John, Wei, Ziwen, Yang, Jing, Raftopoulos, Harry, Pietanza, M. Catherine, Garassino, Marina C

Volltext

Epidemiology of hematological malignancies von Rodriguez-Abreu, D, Bordoni, A, Zucca, E

Volltext

Phase II multicenter, single arm, open label study of nivolumab in combination with ipilimumab in untreated patients with metastatic uveal melanoma (GEM1402.NCT02626962) von Piulats Rodriguez, J.M., De La Cruz Merino, L., Espinosa, E., Alonso Carrión, L., Martin Algarra, S., López-Castro, R., Curiel García, M.T., Rodriguez Abreu, D., Rullan Iriarte, A.J., Berrocal Jaime, A.

Volltext

Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program von Corral, J., Majem, M., Rodríguez-Abreu, D., Carcereny, E., Cortes, Á. A., Llorente, M., López Picazo, J. M., García, Y., Domine, M., López Criado, M P.

Volltext

Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group von Remon, J., Nadal, E., Dómine, M., Ruffinelli, J., García, Y., Pardo, J.C., López, R., Cilleruelo, A., García-Campelo, R., Martín, P., Juan, O., González-Larriba, J.L., Provencio, M., Olmedo, E., Ponce, S., Cumplido, D., Barenys, C., Majem, M., Massutti, B., Rodriguez-Abreu, D., Porta, R., Sala, M.A., Martinez-Kareaga, M., Lianes, P., Reguart, N.

Volltext

SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019) von Majem, M., García-Martínez, E., Martinez, M., Muñoz-Couselo, E., Rodriguez-Abreu, D., Alvarez, R., Arance, A., Berrocal, A., de la Cruz-Merino, L., Lopez-Martin, J. A.

Volltext

The EPICAL trial, a phase Ib study combining first line afatinib with anti-EGF vaccination in EGFR-mutant metastatic NSCLC von Rodríguez-Abreu, D., Cobo, M., García-Román, S., Viteri-Ramírez, S., Jordana-Ariza, N., García-Peláez, B., Reguart, N., Aguilar, A., Codony-Servat, J., Drozdowskyj, A., Molina-Vila, M.A., d'Hondt, E., Rosell, R.

Volltext

OA14.02 IMpower131: Final OS Results of Carboplatin + Nab-Paclitaxel ± Atezolizumab in Advanced Squamous NSCLC von Jotte, R., Cappuzzo, F., Vynnychenko, I., Stroyakovskiy, D., Abreu, D. Rodriguez, Hussein, M., Soo, R., Conter, H., Kozuki, T., Huang, K., Graupner, V., Sun, S., Hoang, T., Jessop, H., Mccleland, M., Ballinger, M., Sandler, A., Socinski, M.

Volltext

KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinu... von Rodriguez Abreu, D., Garassino, M.C., Esteban, E., Speranza, G., Felip, E., Domine, M., Hochmair, M.J., Powell, S.F., Cheng, S.Y.-S., Bischoff, H., Peled, N., Hui, R., Reck, M., Garon, E.B., Boyer, M., Grossi, F., Jennens, R., Yang, J., Pietanza, M.C., Gadgeel, S.M.

Volltext

A randomised phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC: The ETOP and EORTC SPLENDOUR trial von Peters, S., Danson, S.J., Hasan, B., Reinmuth, N., Majem, M., Tournoy, K.G., Mark, M.T., Pless, M., Cobo, M., Rodriguez-Abreu, D., Falchero, L., Massutí, B., Coate, L., von Moos, R., Zielinski, C.C., De Maio, E., O’Brien, M., Roschitzki-Voser, H., Dafni, U., Stahel, R.A.

Volltext

Immune checkpoint blockers in solid organ transplant recipients and cancer: the INNOVATED cohort von Remon, J., Auclin, E., Zubiri, L., Schneider, S., Rodriguez-Abreu, D., Minatta, N., Gautschi, O., Aboubakar, F., Muñoz-Couselo, E., Pierret, T., Rothschild, S.I., Cortiula, F., Reynolds, K.L., Thibault, C., Gavralidis, A., Blais, N., Barlesi, F., Planchard, D., Besse, B.M.D.

Volltext

OA04.06 Evaluation of TMB in KEYNOTE-189: Pembrolizumab Plus Chemotherapy vs Placebo Plus Chemotherapy for Nonsquamous NSCLC von Garassino, M., Rodriguez-Abreu, D., Gadgeel, S., Esteban, E., Felip, E., Speranza, G., Reck, M., Hui, R., Boyer, M., Cristescu, R., Aurora-Garg, D., Albright, A., Loboda, A., Kobie, J., Lunceford, J., Ayers, M., Lubiniecki, G., Piperdi, B., Pietanza, M.C., Garon, E.

Volltext

KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinu... von Rodriguez Abreu, D., Garassino, M.C., Esteban, E., Speranza, G., Felip, E., Domine, M., Hochmair, M.J., Powell, S., Cheng, S.Y.-S., Bischoff, H.G., Peled, N., Hui, R., Reck, M., Garon, E.B., Boyer, M., Grossi, F., Jennens, R., Yang, J., Pietanza, M.C., Gadgeel, S.

Volltext

GECP 1605/NIVEX TRIAL nivolumab in the real world: The SPANISH expanded access program experience in pretreated advanced NSCLC von Majem Tarruella, M., Campillo, J., Grau Béjar, J.F., Carcereny, E., Bernabe Caro, R., Garcia, Y., Artal-Cortes, A., González Cao, M., Lianes, P., Paredes Lario, A., Sereno Moyano, M., Mielgo Rubio, X., Macias, J.A., Provencio Pulla, M., Rodriguez-Abreu, D.

Volltext

Survival in young adults diagnosed with follicular lymphoma von Calvo, V., Provencio, M., Gómez Codina, J., Rodríguez Abreu, D., Rueda, A.

Volltext

First analysis of patients (p) with stage IV non-small cell lung cancer (NSCLC) of the thoracic tumor registry (RTT) of the Spanish Lung Cancer Group (SLCG) von Carcereny Costa, E., Rodriguez-Abreu, D., Guirado, M., López-Castro, R., Massutí, B., Bosch Barrera, J., Nogueron Martnez, E., Sala Gonzalez, M.A., Domine Gomez, M., Del Barco Morillo, E., Cerezo Gonzalez, S., Dorta Suarez, M., Casal Rubio, J., Camps, C., Muñoz, M.A., de las Peñas, R., Ortega dominguez, J.A., Gonzalez-Larriba, J.L., Bernabe Caro, R., Provencio Pulla, M.

Volltext

Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer—final results of the EUCROSS trial von Michels, S., Massutí, B., Vasyliv, I., Stratmann, J., Frank, J., Adams, A., Felip, E., Grohé, C., Rodriguez-Abreu, D., Bischoff, H., Carcereny i Costa, E., Corral, J., Pereira, E., Fassunke, J., Fischer, R.N., Insa, A., Koleczko, S., Nogova, L., Reck, M., Reutter, T., Riedel, R., Schaufler, D., Scheffler, M., Weisthoff, M., Provencio, M., Merkelbach-Bruse, S., Hellmich, M., Sebastian, M., Büttner, R., Persigehl, T., Rosell, R., Wolf, J.

Volltext

3074 Platinum-pemetrexed palliative chemotherapy in malignant pleural mesothelioma from Spanish BEMME database The Spanish Lung Cancer Group (SLCG) von Remon, J, Reguart, N, Garcia, Y, Nadal, E, Lopez-castro, R, Garcia-campelo, R, Martin-martorell, P, Juan, O, Olmedo, E, Trancho, F, Domine, M, Ponce, S, Cumplido, D, Majem, M, Massuti, B, Porta, R, Rodriguez-abreu, D, Provencio, M

Volltext